Direct distribution
July 14, 2011
THE National Pharmaceutical
Services Association (NPSA) has
launched a new campaign to
raise awareness of the health
implications caused by Pfizer’s
direct distribution decision.
Titled, No Monopoly on the
Supply of Medicines to Your
Pharmacy, the campaign calls on
pharmacists to get customers to
sign a petition to the House of
Representatives which asks the
Government to introduce an
amendment to the Health Act
that prohibits exclusive supply
of PBS medicines by
manufacturers to community
pharmacies.
According to the NPSA, the
action was launched in
response to the growing
number of pharmacists calling
for action because Pfizer’s
decision has made it more
difficult for them to meet the
needs of their patients.
“Patient care is being
compromised because of this
exclusive supply model,” said
campaign participant, Joe Saleh,
Compounding Pharmacy Newport.
As part of the campaign,
pharmacists will also display
posters, hand out information
flyers and contact their local
member of parliament over the
negative impact of direct
distribution on patients.
Pharmacists are also
requested to direct consumers
to the campaign website which
lists affected medicines,
including drugs for life
threatening conditions - see,
nomonopolyonmedicine.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jul 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jul 11
